Found 1329 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: Hormone_recep

Total Genus Sequence Length pdb Title
79 222 6ln4A Estrogen-related receptor beta(err2) in complex with pgc1a-2a
80 198 6litA Estrogen-related receptor beta(err2) in complex with bpa
87 299 6t2mA Vdr-zk168281 complex
83 213 7jh2A Crystal structure of rar-related orphan receptor c in complex with a potent, selective and orally bioavailable ror-gamma-t inverse agonist
80 221 6xfvA Crystal structure of rar-related orphan receptor c in complex with a novel inverse agonist
82 222 6knrA Crystal structure of estrogen-related receptor gamma ligand-binding domain with dn200699
99 263 6kxxA Human ppar alpha ligand binding domain in complex with a synthetic agonist (compound a)
102 263 6kxyA Human ppar alpha ligand binding domain in complex with a synthetic agonist (compound b)
76 259 6k9mA Human lxr-beta in complex with an agonist
86 227 6k3nA Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bpa-monof
92 265 6xaeA Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t agonists
84 240 6wokA Crystal structure of estrogen receptor alpha in complex with receptor degrader 6
85 228 6vswA Optimization and biological evaluation of thiazole-bis-amide inverse agonists of rorgt
87 238 6vifA Human lrh-1 ligand-binding domain bound to agonist cpd 15 and fragment of coregulator tif-2
99 273 6tsgA Crystal structure of peroxisome proliferator-activated receptor gamma (pparg) in complex with tetrac
98 265 6u25A Crystal structure of rar-related orphan receptor c (nhis- rorgt(244-487)-l6-src1(678-692)) in complex with a tricyclic inverse agonist
84 250 6suoA Era_l536s (l536s/c381s/c471s,c530s) in complex with a tricyclic indole (compound 6)
91 270 6o68A Crystal structure of human ppargamma ligand binding domain in complex with ciglitazone
101 273 6k0tA Crystal structure of ppargamma ligand binding domain in complex with dibenzooxepine derivative compound-17
90 259 6nwuA Rorgamma ligand binding domain
94 259 6nwsA Rorgamma ligand binding domain
91 233 6nwtA Rorgamma ligand binding domain
104 270 6a6pA Crystal structure of peroxisome proliferator-activated receptor delta (ppard)lbd in complex with dn003316
79 251 4ummF The cryo-em structure of the palindromic dna-bound usp-ecr nuclear receptor reveals an asymmetric organization with allosteric domain positioning
89 243 4ummG The cryo-em structure of the palindromic dna-bound usp-ecr nuclear receptor reveals an asymmetric organization with allosteric domain positioning
84 385 4nqaB Crystal structure of liganded hrxr-alpha/hlxr-beta heterodimer on dna
83 329 4nqaA Crystal structure of liganded hrxr-alpha/hlxr-beta heterodimer on dna
97 320 4iqrA Multi-domain organization of the hnf4alpha nuclear receptor complex on dna
111 371 3e00D Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with gw9662, 9-cis retinoic acid and ncoa2 peptide
91 324 3dzuA Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with bvt.13, 9-cis retinoic acid and ncoa2 peptide
83 324 3dzyA Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with rosiglitazone, 9-cis retinoic acid and ncoa2 peptide
102 370 3dzyD Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with rosiglitazone, 9-cis retinoic acid and ncoa2 peptide
104 370 3dzuD Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with bvt.13, 9-cis retinoic acid and ncoa2 peptide
79 324 3e00A Intact ppar gamma - rxr alpha nuclear receptor complex on dna bound with gw9662, 9-cis retinoic acid and ncoa2 peptide
106 271 5z6sA Crystal structure of the ppargamma-lbd complexed with compound ds-6930
90 230 5za1A Ligand complex of rorgt lbd
91 228 5y1jA Crystal structure of human fxr in complex with a functional drug ligand
101 269 6ad9A Crystal structure of ppargamma ligand binding domain in complex with dibenzooxepine derivative compound-9
81 228 6a5zA Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc180 and 9cra and src1
85 228 6a5wA Fxr-lbd with hnc143 and src1
82 230 6a5yD Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc143 and 9cra and src1
67 228 6a60A Crystal structure of human fxr/rxr-lbd heterodimer bound to gw4064 and 9cra and src1
102 271 5z5sA Crystal structure of the ppargamma-lbd complexed with compound 13ab
79 229 6a5zD Crystal structure of human fxr/rxr-lbd heterodimer bound to hnc180 and 9cra and src1
100 268 6mczA Crystal structure of human ppargamma ligand binding domain in complex with arachidonic acid
98 268 6md4A Crystal structure of human ppargamma ligand binding domain in complex with rosiglitazone and oleic acid
97 268 6md2A Crystal structure of human ppargamma ligand binding domain in complex with gw9662 and arachidonic acid
86 227 6ivxA Discovery of the second generation ror gamma inhibitors composed of an azole scaffold.
99 268 6md0A Crystal structure of human ppargamma ligand binding domain in complex with oleic acid
95 269 6md1A Crystal structure of human ppargamma ligand binding domain in complex with gw9662 and oleic acid